Literature DB >> 22391625

Genetic skin diseases predisposing to basal cell carcinoma.

Marco Castori1, Aldo Morrone, Jean Kanitakis, Paola Grammatico.   

Abstract

Basal cell carcinoma (BCC) is the commonest cancer in humans. Predisposing factors reflect common genetic variations and environmental influences in most cases. However, an underlying Mendelian disorder should be suspected in a specific subset of patients, namely those with multiple, early onset lesions. Some specific conditions, including Gorlin, Bazex-Dupré-Christol and Rombo syndromes, and Xeroderma Pigmentosum, show BCC as a prominent feature. In addition, BCC may represent a relatively common, although less specific, finding in many other genodermatoses. These include disorders of DNA replication/repair functions (Bloom, Werner, Rothmund-Thomson and Muir-Torre syndromes), genodermatoses affecting the folliculo-sebaceus unit (Brooke-Spiegler, Schöpf-Schulz-Passarge and Cowden syndromes), immune response (cartilage-hair hypoplasia and epidermodysplasia verruciformis) and melanin biosynthesis (oculocutaneous albinism and Hermansky-Pudlak syndrome), and some epidermal nevus syndromes. Further conditions occasionally associated with BCCs exist, but the significance of the association remains to be proven.

Entities:  

Mesh:

Year:  2012        PMID: 22391625     DOI: 10.1684/ejd.2011.1633

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  19 in total

Review 1.  Keratinocyte Carcinomas: Current Concepts and Future Research Priorities.

Authors:  Priyadharsini Nagarajan; Maryam M Asgari; Adele C Green; Samantha M Guhan; Sarah T Arron; Charlotte M Proby; Dana E Rollison; Catherine A Harwood; Amanda Ewart Toland
Journal:  Clin Cancer Res       Date:  2018-12-06       Impact factor: 12.531

2.  A novel tumor suppressor gene in basal cell carcinoma: inhibition of growth factor-2.

Authors:  Metin Temel; Arif Turkmen; Recep Dokuyucu; Cengiz Cevik; Serdar Oztuzcu; Beyhan Cengiz; Mehmet Mutaf
Journal:  Tumour Biol       Date:  2015-01-23

3.  Systemic therapy for inoperable and metastatic basal cell cancer.

Authors:  Leslie A Fecher
Journal:  Curr Treat Options Oncol       Date:  2013-06

4.  Nonsurgical Options for the Treatment of Basal Cell Carcinoma.

Authors:  John Paoli; Johan Dahlén Gyllencreutz; Julia Fougelberg; Eva Johansson Backman; Maja Modin; Sam Polesie; Oscar Zaar
Journal:  Dermatol Pract Concept       Date:  2019-04-30

Review 5.  Genetic and environmental factors underlying keratinocyte carcinoma risk.

Authors:  Hélène Choquet; Sepideh Ashrafzadeh; Yuhree Kim; Maryam M Asgari; Eric Jorgenson
Journal:  JCI Insight       Date:  2020-05-21

Review 6.  RNA-based therapies for genodermatoses.

Authors:  Olivier Bornert; Patricia Peking; Jeroen Bremer; Ulrich Koller; Peter C van den Akker; Annemieke Aartsma-Rus; Anna M G Pasmooij; Eva M Murauer; Alexander Nyström
Journal:  Exp Dermatol       Date:  2017-01       Impact factor: 3.960

7.  Extrinsic aging: UV-mediated skin carcinogenesis.

Authors:  Fragkiski Tsatsou; Myrto Trakatelli; Aikaterini Patsatsi; Konstantinos Kalokasidis; Dimitrios Sotiriadis
Journal:  Dermatoendocrinol       Date:  2012-07-01

Review 8.  Photodynamic therapy in the treatment of basal cell carcinoma.

Authors:  C Matei; M Tampa; T Poteca; G Panea-Paunica; S R Georgescu; R M Ion; S M Popescu; C Giurcaneanu
Journal:  J Med Life       Date:  2013-03-25

Review 9.  Oculocutaneous Albinism and Squamous Cell Carcinoma of the Skin of the Head and Neck in Sub-Saharan Africa.

Authors:  P T Lekalakala; R A G Khammissa; B Kramer; O A Ayo-Yusuf; J Lemmer; L Feller
Journal:  J Skin Cancer       Date:  2015-08-12

Review 10.  Telomere-regulating genes and the telomere interactome in familial cancers.

Authors:  Carla Daniela Robles-Espinoza; Martin del Castillo Velasco-Herrera; Nicholas K Hayward; David J Adams
Journal:  Mol Cancer Res       Date:  2014-09-22       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.